Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. News
  7. Most relevant
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
Delayed Nasdaq Helsinki  -  11:22 2022-09-23 am EDT
3.220 EUR   -1.53%
09/18Certain Shares of Nanoform Finland Oyj are subject to a Lock-Up Agreement Ending on 18-SEP-2022.
CI
09/07Nanoform Finland Plc - Manager's transactions - Niklas Sandler
AQ
09/06Share subscriptions based on Nanoform Finland Plc's stock options 2-3/2019 and 1/2020
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NANOFORM FINLAND OYJ
09/18Certain Shares of Nanoform Finland Oyj are subject to a Lock-Up Agreement Ending on 18-..
CI
09/07Nanoform Finland Plc - Manager's transactions - Niklas Sandler
AQ
09/06Share subscriptions based on Nanoform Finland Plc's stock options 2-3/2019 and 1/2020
AQ
08/25TRANSCRIPT : Nanoform Finland Oyj, H1 2022 Earnings Call, Aug 25, 2022
CI
08/25NANOFORM FINLAND OYJ : Interim Report for January-June 2022
PU
08/25NANOFORM Q2 AND H1 2022 REPORT : Strong momentum continues
AQ
08/25Nanoform Finland Oyj Reports Earnings Results for the Second Quarter and Six Months End..
CI
08/10Invitation to Nanoform's Interim Report January-June 2022
AQ
07/14Nanoform and Pharmanovia to breathe new life into iconic medicines
AQ
07/14Nanoform Finland Plc Partners with Pharmanovia for Iconic Medicines
CI
06/13Nanoform Chief of Business Operations Gonçalo Andrade steps down
AQ
06/13Nanoform's Gonçalo Andrade Steps Down as Chief of Business Operations
CI
06/13Nanoform Finland Plc - Manager's transactions - Jeanne Thoma
AQ
06/13Nanoform Finland Plc - Manager's transactions - Albert Hæggström
AQ
06/13Nanoform Finland Plc - Manager's transactions - Mads Laustsen
AQ
06/06Share subscriptions based on Nanoform Finland Plc's stock options 1-2/2019 and 1/2020
AQ
06/06The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key..
AQ
06/06Nanoform Finland Plc - Manager's transactions - Miguel Calado
AQ
06/02NANOFORM FINLAND OYJ : Plc – Manager's transactions – Niklas Sandler
PU
06/02Nanoform Finland Plc - Manager's transactions - Niklas Sandler
AQ
05/30Nanoform Finland Plc - Manager's transactions - Gonçalo Andrade
AQ
05/24TRANSCRIPT : Nanoform Finland Oyj, Q1 2022 Earnings Call, May 24, 2022
CI
05/24NANOFORM 1Q 2022 REPORT : Quarterly record of new projects and new customers
AQ
05/24Nanoform Finland Oyj Reports Earnings Results for the First Quarter Ended March 31, 202..
CI
05/10Invitation to Nanoform's Interim Report January-March 2022
AQ
05/04Nanoform Finland Plc. Launches "STARMAP® Online" Placing AI-Power at the Fingertips of ..
CI
05/04Nanoform launches "STARMAP Online" placing AI-power at the fingertips of medicine devel..
AQ
04/12Nanoform Finland Plc - Manager's transactions - Niklas Sandler
AQ
04/12Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland P..
AQ
04/12Share subscriptions based on Nanoform Finland Plc's multiple Stock Option Programs
AQ
04/12Nanoform Finland Elects Members to Audit and Compensation Committee
CI
04/12Resolutions of Nanoform Finland Plc's Annual General Meeting on April 12, 2022
AQ
03/25Nanoform Finland Plc - Manager's transactions - Gonçalo Andrade
AQ
03/24Herantis PharmaAnnounces Successful HER-096 Initial Results with Nanoform Technology
AQ
03/23New shares of Nanoform registered with the trade register
AQ
03/22Nanoform Finland Raises $28 Million To Prepare For GMP Manufacturing In US
MT
03/22Nanoform Finland Plans $28 Million Capital Raise to Fund New Manufacturing Site in US
MT
03/22Nanoform successfully completes new share issue raising EUR 25 million to prepare for G..
AQ
03/22Nanoform to Prepare for GMP Manufacturing in the USA
CI
03/22Nanoform announces its intention to carry out a new share issue to raise approximately ..
AQ
03/17Notice to the Annual General Meeting of NANOFORM FINLAND Plc
AQ
03/12NANOFORM FINLAND OYJ : triples its GMP capacity and adds high potent handling (OEL <30 ng/..
PU
02/22TRANSCRIPT : Nanoform Finland Oyj, Q4 2021 Earnings Call, Feb 22, 2022
CI
02/22NANOFORM 4Q AND FULL YEAR 2021 REPOR : accelerating GMP growth
AQ
02/22Nanoform Finland Oyj Provides Earnings Guidance or the Year 2025
CI
02/22Nanoform Finland Oyj Reports Earnings Results for the Fourth Quarter Ended December 31,..
CI
02/22Nanoform Finland Oyj Reports Earnings Results for the Full Year Ended December 31, 2021
CI
02/08Invitation to Nanoform's Q4 and full year 2021 report February 22, 2022
AQ
02/04Nanoform signs GMP manufacturing program with TargTex following formulation success
AQ
02/04Nanoform signs GMP manufacturing program with TargTex following formulation success
CI
01/03Nanoform sets two new near-term business targets for 2022
AQ
2021Nanoform financial calendar for 2022
AQ
2021NANOFORM FINLAND OYJ : Interim Report January – September 2021
PU
2021Nanoform Interim Report January - September 2021
AQ
2021Nanoform Finland Oyj Reports Earnings Results for the Third Quarter and Nine Months End..
CI
2021NANOFORM FINLAND OYJ : Interim Report for January-September 2021 – Report
PU
2021Resolutions of Nanoform Finland Plc's Extraordinary General Meeting on November 17, 202..
AQ
2021Nanoform Finland Oyj Elects Jeanne Thoma as New Member of the Board
CI
2021Nanoform wins Star of Innovation award at the European Small and Mid-Cap Awards 2021
AQ
2021Nanoform signs GMP agreement and achieves near-term business target
AQ
2021Nanoform Signs GMP Agreement and Achieves Near-Term Business Target
CI
2021NANOFORM RECEIVES ISO/IEC 27001 : 2013 certification for its Information Security Manageme..
AQ
2021Invitation to presentation of Nanoform's Q3/2021 report on November 25, 2021
PU
2021Invitation to presentation of Nanoform's Q3/2021 report on November 25, 2021
AQ
2021NANOFORM FINLAND OYJ : trailblazing progress earns recognition from prestigious industry a..
PU
2021NANOFORM FINLAND OYJ : Notice to the Extraordinary General Meeting of NANOFORM FINLAND PLC
AQ
2021NANOFORM FINLAND OYJ : convenes EGM to elect Jeanne Thoma as board member
AQ
2021NANOFORM FINLAND OYJ : receives funding to solve challenges for global health
AQ
2021NANOFORM FINLAND OYJ : Plc – Manager's transactions – Gonçalo Andrade
PU
2021NANOFORM FINLAND PLC : - Manager's transactions - Gonçalo Andrade
AQ
2021NANOFORM FINLAND OYJ : shortlisted for the European Small and Mid-Cap Awards 2021
AQ
2021NANOFORM FINLAND OYJ : Herantis Pharma Complete Parkinson's Drug Combo Proof Of Concept
MT
2021NANOFORM FINLAND OYJ : technology delivers successful results for Herantis CDNF drug candi..
AQ
2021HERANTIS PHARMA OYJ : Announces Successful rhCDNF Results With Nanoform Technology
AQ
2021Nanoform technology delivers successful results for Herantis CDNF drug candidate
CI
1  2  3Next
Upcoming event on NANOFORM FINLAND OYJ